CYRX - Cryoport enters supply chain solutions contract with Boston IVF

2023-04-25 10:34:43 ET

• Global provider of innovative temperature-controlled supply chain solutions for the life sciences, reproductive medicine and animal health industries, Cryoport ( NASDAQ: CYRX ) signed a new three-year agreement with Boston IVF.
• Cryoport's platform will improve the overall efficiency of Boston IVF's reproductive material shipments and ensure significant risk mitigation for patients and families entrusting Boston IVF with their care.
• Jerrell Shelton, CEO "As we seek to provide more patients with peace of mind that their reproductive materials are being handled safely and securely, we're proud to partner with a team that is equally committed to delivering the best outcomes and experiences for their patients."

For further details see: